Assenagon Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.99M | Sell |
|
|||||
|
2025
Q2 | $11.5M | Sell |
|
|||||
|
2025
Q1 | $16.7M | Buy |
|
|||||
|
2024
Q4 | $8.52M | Sell |
|
|||||
|
2024
Q3 | $8.32M | Buy |
|
|||||
|
2024
Q2 | $3.82M | Sell |
|
|||||
|
2024
Q1 | $5.74M | Sell |
|
|||||
|
2023
Q4 | $8.32M | Buy |
|
|||||
|
2023
Q3 | $2.65M | Sell |
|
|||||
|
2023
Q2 | $8.33M | Buy |
|
|||||
|
2023
Q1 | $6.2M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $8.45M | Buy |
|
|||||
|
2021
Q3 | $1.77M | Sell |
|
|||||
|
2021
Q2 | $4.17M | Hold |
|
|||||
|
2021
Q1 | $4.82M | Sell |
|
|||||
|
2020
Q4 | $4.12M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $3.84M | Buy |
|